Epidemiology News and Research

RSS

Brazilian breast cancer drug market to grow from $424M in 2009 to $611M in 2014: Decision Resources

Decision Resources, one of the world's leading research and advisory firms focusing on pharmaceutical and healthcare issues, finds that the breast cancer drug market in Brazil will grow from $424 million in 2009 to $611 million in 2014. Factors promoting the market's growth include steady increases in the number of incident breast cancer cases, shifts toward higher-cost chemotherapy and hormonal regimens in the adjuvant setting and increases in the use of targeted therapies following novel product launches and label extensions.

16 Jun 2010

RG7204 holds promise for metastatic melanoma with V600E BRAF mutation

Preclinical findings recently published in Cancer Research, a journal of the American Association for Cancer Research, showed RG7204 (PLX4032) inhibited proliferation of tumor cell lines that expressed V600E-BRAF, a mutation found in several human cancers, including melanoma.

16 Jun 2010

ESC, EACPR urges MEPs to vote in favour of traffic light system for food labelling

The European Society of Cardiology http://www.escardio.org/ and its branch, the European Association for Cardiovascular Prevention and Rehabilitation http://www.escardio.org/communities/EACPR/Pages/welcome.aspx, are joining forces with 12 other European Health and consumer communities to urge MEPs to vote in favour of a traffic light system for food labelling today.

16 Jun 2010

Prevalence of GID in PD patients has impact on clinical and societal outcomes: Study

New data from a retrospective cohort study showed that up to three quarters of patients with Parkinson's disease developed gastrointestinal disorders that can have a substantial adverse effect on major PD-related clinical and health economic outcomes. These data were presented at the 14th International Congress of Parkinson's Disease and Movement Disorders in Buenos Aires, Argentina (June 13-17, 2010).

16 Jun 2010

FDA unveils safety reports on recently approved drugs, biologics

The U.S. Food and Drug Administration today unveiled a new source of information for patients and health care professionals on the safety of recently approved drugs and biologics.

16 Jun 2010

Combination of BRAF-targeted therapy and immunotherapy shows promise for treatment of melanoma

Combined targeted therapy against the BRAF/MAPK pathway with immunotherapy shows promise as a new therapeutic approach for the treatment of melanoma, according to results of a preclinical study published in Cancer Research, a journal of the American Association for Cancer Research.

16 Jun 2010

Eating Mediterranean-style diet reduces heart disease risk: Research

A study of twins shows that even with genes that put them at higher risk of cardiovascular disease, eating a Mediterranean-style diet can improve heart function, according to research reported in Circulation: Cardiovascular Quality and Outcomes, an American Heart Association journal.

16 Jun 2010

Prostate cancer deaths are expected to jump 17%: 2010 statistics

Prostate cancer deaths are expected to jump 17 percent this year, according to estimates based on National Cancer Institute data. The alarming 2010 statistics, just prior to Father's Day, has ZERO – The Project to End Prostate Cancer urging families to encourage Dad to get tested for the disease this Father's Day because prostate cancer is the second leading cancer among American men.

16 Jun 2010

Researchers examine rates of cancer in British white and British Indian population

British Indians have fewer cases of many different cancers including breast, prostate, colon and lung than the British white population, according to new research published in the British Journal of Cancer1 today (Wednesday).

16 Jun 2010

UBC announces launch of new office in Lörrach, Germany

United BioSource Corporation today announced the launch of a new office in Lörrach, Germany, further expanding the company's clinical research and medical affairs capabilities in Europe. The Lörrach office is located near Basel, Switzerland and is the 10th UBC office to open in Europe, adding to facilities in the United Kingdom, Switzerland, Ukraine, Spain, Sweden, Hungary and the Czech Republic.

15 Jun 2010

Early administration of tranexamic acid to patients with severe bleeding injuries saves lives

If recently injured patients with serious bleeding were to receive a cheap, widely available and easily administered drug to help their blood to clot, tens of thousands of lives could be saved every year, according to a paper published on-line today by The Lancet.

15 Jun 2010

Medicare coverage of unproven mammography screening device leads to surge in usage

In a study illustrating the potentially powerful influence of political pressure on medical practice, a UC Davis physician-researcher has found that use of a largely unproven mammography screening device has surged since Medicare began covering its cost.

15 Jun 2010

Cheap drug that prevents bleeding may save 100,000 lives each year: Study

Researchers have shown that a cheap and easy to use drug that stops bleeding may save up to 100,000 lives each year from injuries associated with road accidents and violence. The study was published this Tuesday in the acclaimed international journal The Lancet and was conducted by doctors at the London School of Hygiene and Tropical Medicine.

14 Jun 2010

Evidence-based review of TBI in sport

Experts from Johns Hopkins Medicine hosted a press conference following a continuing medical education program on the epidemiology of head injury in professional football. The program was an evidence-based review of traumatic brain injury in the sport.

14 Jun 2010

DFG sets up new Research Training Groups for German researchers

To further enhance the promotion of young researchers in Germany, the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) has established twelve new Research Training Groups.

14 Jun 2010

Emerging science of epigenetics offers new insights at crossroads of genes and the environment: Article

An emerging arm of molecular biology is introducing a new interpretation of traditional concepts of human disease, explains an article published today in Nature. According to author Dr. Arturas Petronis at the Centre for Addiction and Mental Health, the emerging science of epigenetics is offering new insights at the crossroads of genes and the environment, or nature and nurture. Dr. Petronis is head of the Krembil Family Epigenetics Laboratory at CAMH and an international expert in the field.

11 Jun 2010

Type 2 diabetes doubles risk of cancer in women

Type 2 adult-onset diabetes causes insulin-like hormones to circulate through the body. A new study finds this has a surprisingly positive effect on reducing the rate of prostate cancer in men, but is bad news for women: Type 2 diabetes may double the risk of female genital and other cancers.

11 Jun 2010

Non-melanoma skin cancer is potential marker for survivors at risk for future malignant tumors

Childhood cancer survivors diagnosed later with non-melanoma skin cancer may be at increased risk for having a malignant tumor within 15 years, according to research led by St. Jude Children's Research Hospital investigators.

10 Jun 2010

AASLD recommends surveillance in patients with cirrhosis who are at high risk of developing HCC

A study conducted by researchers at the Baylor College of Medicine found that fewer than 20% of patients with hepatocellular carcinoma preceded by cirrhosis were monitored for the development of cancer. Full findings of this study are published in the July issue of Hepatology, a journal of the American Association for the Study of Liver Diseases .

10 Jun 2010

People who smoke immediately after waking may be at risk for lung cancer: Study

People who smoke their first cigarette within minutes after waking up have much higher levels of cotinine, a by-product of nicotine when processed by the body, than those who wait to smoke, regardless of the number of cigarettes smoked.

10 Jun 2010

Epidemiology News and Research

Brazilian breast cancer drug market to grow from $424M in 2009 to $611M in 2014: Decision Resources

RG7204 holds promise for metastatic melanoma with V600E BRAF mutation

ESC, EACPR urges MEPs to vote in favour of traffic light system for food labelling

Prevalence of GID in PD patients has impact on clinical and societal outcomes: Study

FDA unveils safety reports on recently approved drugs, biologics

Combination of BRAF-targeted therapy and immunotherapy shows promise for treatment of melanoma

Eating Mediterranean-style diet reduces heart disease risk: Research

Prostate cancer deaths are expected to jump 17%: 2010 statistics

Researchers examine rates of cancer in British white and British Indian population

UBC announces launch of new office in Lörrach, Germany

Early administration of tranexamic acid to patients with severe bleeding injuries saves lives

Medicare coverage of unproven mammography screening device leads to surge in usage

Cheap drug that prevents bleeding may save 100,000 lives each year: Study

Evidence-based review of TBI in sport

DFG sets up new Research Training Groups for German researchers

Emerging science of epigenetics offers new insights at crossroads of genes and the environment: Article

Type 2 diabetes doubles risk of cancer in women

Non-melanoma skin cancer is potential marker for survivors at risk for future malignant tumors

AASLD recommends surveillance in patients with cirrhosis who are at high risk of developing HCC

People who smoke immediately after waking may be at risk for lung cancer: Study

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News